|
Followers
|
7
|
Posters
|
|
|
Posts (Today)
|
0
|
Posts (Total)
|
87
|
|
Created
|
01/16/11
|
Type
|
Free
|
| Moderators | |||
Name: CIGNA Corporation
Ticker Symbol: NYSE: CI
Business: The company provides health care and related benefits, the majority of which are offered through the workplace, including: health care products and services (insured and self-funded medical, dental, behavioral health, vision, and prescription drug benefit plans, health advocacy programs); group disability, life and accident insurance. In addition, the Company has an international operation that offers life, accident and supplemental health insurance products as well as international health care products and services to businesses and individuals in selected markets.
Strategy: As a global health service organization, CIGNA's mission remains focused on helping the people it serves improve their health, well-being and sense of security. CIGNA's long-term growth strategy is based on: (1) growth in targeted geographies, product lines, buying segments and distribution channels; (2) improving its strategic and financial flexibility; and (3) pursuing additional opportunities in high-growth markets with particular focus on individuals.
As of December 31, 2009:
Full-Year Revenues: $18.4 billion
Total shareholders' equity: $5.4 billion
CIGNA Executive Management Team
* David M. Cordani, President and CEO, CIGNA Corporation
* William Atwell, President, CIGNA International, CIGNA Corporation
* Philip Emond, Executive Vice President and Chief Information Officer, CIGNA Corporation
* Maggie FitzPatrick, Chief Communications Officer, CIGNA Corporation
* Jeffrey Kang, MD, MPH, Chief Medical Officer, CIGNA Corporation
* Matt Manders, U.S. Service, Clinical and Specialty
* Thomas A. McCarthy, Acting Chief Financial Officer, CIGNA Corporation
* John M. Murabito, Executive Vice President, Human Resources and Services, CIGNA Corporation
* Carol Ann Petren, Executive Vice President and General Counsel, CIGNA Corporation
* Bertram L. Scott , President, U.S. Commercial, CIGNA Corporation
Investor Relations Contacts
To help us appropriately direct your inquiry, please choose from the following:
If you are: A current or prospective investor in CIGNA and have questions about our business, please contact:
Ted Detrick, Vice President, Investor Relations
215.761.1414
edwin.detrick@cigna.com
Brent Sanders, Financial Analysis Senior Director
215.761.5417
brent.sanders@cigna.com
Victoria (Vicki) Arndt, Financial Analysis Director
215.761.1609
victoria.arndt@cigna.com
If you are: a current or prospective CIGNA common-stock shareholder and have questions about the Direct Stock Purchase Plan, dividend payments or stock transfers, please contact:
Mellon Investor Services
P.O. Box 3315
South Hackensack, NJ 07606-9915
Telephone:
800.760.8864 (Domestic)
201.329.8320 (International)
Web address
http://www.melloninvestor.com
http://www.cigna.com
CIGNA Tel-Drug is recognized by the National Association Boards of Pharmacy as a Verified Internet Pharmacy Practice Site (VIPPS).
Tel-Drug, Inc/CIGNA
www.teldrug.com
| Corporation Tel-Drug, Inc/CIGNA | Phone 605-373-0100 |
| Address 4901 N. 4th Ave Sioux Falls, SD 57104-0444 | C. Daniel Haron President |
| State of Incorporation SD | Experience Operating a Pharmacy Since 1993 |
| Dispensing Pharmacies | ||
| Pharmacy Name | Address | |
| Tel-Drug of Pennsylvania, LLC | 206 Welsh Road Horsham, PA 10944 |  |
| Tel-Drug, Inc/CIGNA | 4901 N. 4th Avenue Sioux Falls, SD 57104 | |
| To report medication / device problems: |
| Click www.teldrug.com or call 800-835-3784 |
| To report business compliance problems: |
| Click www.teldrug.com or call 800-835-3784 |
| Original VIPPS Accreditation Date | Expiration Date |
| May 25, 2000 | May 25, 2012 |
